Tag: pharmaceuticals
-

Asthma Drug Shown to Lower Airway Muscle Mass
An experimental drug is shown in a clinical trial and computer modeling to reduce the mass of smooth muscle tissue that builds up in airways of people with asthma.
-

FDA Approves 25 Precision Meds in 2018
An organization advocating for medicines addressing a person’s unique chemical composition rather than disease symptoms says U.S. regulators approved 25 of those drugs in 2018.
-

Insulin Delivered by Capsule, That’s the Good News
Before we start celebrating the end of injections, we need to deal with a more basic problem facing people with diabetes, namely the rapidly rising cost of insulin.
-

Trial Testing Vaginal Ring, PrEP in Teens, Young Women
A clinical trial is underway testing use and preferences for drugs or a medical device to prevent HIV infection among young women and teenage girls in Africa.
-

Capsule Designed to Inject Insulin in Stomach Wall
A biomedical engineering team created a capsule that in animal tests releases a tiny needle delivering an insulin dose to the stomach lining, equivalent to conventional insulin injections.
-

Company to Stop Cancer Spread, Relapse Raises $60.8M
A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing.
-

Large Molecule Library Enables On-Demand Drug Discovery
A large-scale public drug molecule library is shown with computational modeling to accurately identify on-demand new compounds that bind completely to therapy targets.
-

Brain Tissue Model Devised for Cancer Drug Testing
A three-dimensional brain tissue model, including a patient’s tumor cells, shows in lab tests an ability to test current and experimental cancer drugs.
-

Wearables Assessed for Clinical Trial Value
An evaluation of wearable devices shows their value for collecting useful data in a clinical trial can vary depending on the purpose of the device.
-

Natural Enemy Shown Effective Against Staph Bacteria
A clinical trial shows adding a treatment for drug-resistant infections based on the bacteria’s natural enemies kills more Staphylococcus aureus bacteria than standard antibiotics alone.